Objective To retrospectively evaluate choroidal thickness after treatment by photodynamic therapy (PDT) or laser photocoagulation (LP) in eyes with acute central serous chorioretinopathy (CSC) using enhanced depth imaging spectral-domain optical coherence tomography (EDI-OCT). Methods In this retrospective study, 39 eyes of 39 patients with idiopathic acute CSC were recruited, after the following comprehensive ocular examinations were performed: best-corrected visual acuity (BCVA), slit-lamp biomicroscopy, indirect ophthalmoscopy, fundus photography, fluorescein angiography (FFA), and indocyanine green angiography (ICGA). Patients were divided into 2 types based on FFA characteristics: points of leakage in the foveal avascular zone (FAZ) and points of leakage out from the FAZ. The first type, which is not amenable to LP, was treated with a half-dose of verteporfin PDT guided by ICGA, whereas the other type was treated with LP. Subfoveal choroidal thickness and choroidal thickness at 1500 μm temporal, nasal, superior, and inferior to the fovea were measured. The choroidal thickness was measured with enhanced depth imaging OCT before treatment at baseline, and 1 and 3 months after treatment. The results of the choroidal thickness measurements were analyzed using a repeated measurement ANOVA. Results In the PDT group, choroidal thickness at all evaluating points had decreased significantly within 3 months compared to baseline. Whereas in the LP group, choroidal thickness had decreased significantly within 3 months only at 1500 μm superior and temporal to the fovea compared to baseline. Conclusion PDT reduces choroidal vascular hyperpermeability by remodeling the choroidal vascular system resulting in the reduction of choroidal thickness in the macular region and may work by a different mechanism than LP, which targets RPE.
李岩,曲鹏,郑微微,孙祖华,林冰,罗文,刘晓玲. 中心性浆液性脉络膜视网膜病变治疗前后脉络膜厚度的短期观察[J]. 中华眼视光学与视觉科学杂志, 2013, 15(1): 14-17.
LI Yan,QU Peng,ZHENG Wei-wei,SUN Zu-hua,LIN Bin,LUO Wen,LIU Xiao-ling. OCT-EDI characteristics of choroidal thickness shortly after treatment for acute central serous chorioretinopathy in patients. Chinese Journal of Optometry Ophthalmology and Visual Science, 2013, 15(1): 14-17. DOI: 10.3760/cma.j.issn.1674-845X.2013.01.004
Klais CM, Ober MD, Ciardella AP, et al. Central serous chorioretinopathy. In Ryan SJ, ed-in-chief, Hinton DR, Schachat AP, Wilkinson CP, eds. Retina. 4th ed. vol. 2. Philadelphia: Elsevier Mosby, 2006:1135-1161.
[2]
Gass JD. Pathogenesis of disciform detachment of the neuro-epithelium. II. Idiopathic central serous choroidopathy. Am J Ophthalmol,1967,63:587-615.
[3]
Piccolino FC, Borgia L. Central serous chorioretinopathy and indocyanine green angiography. Retina,1994,14:231-42.
[4]
Iida T, Kishi S, Hagimura N, et al. Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina,1999,19:508-512.
Pryds A, Larsen M. Choroidal thickness following extrafoveal photodynamic treatment with verteporfin in patients with central serous chorioretinopathy. Acta Ophthalmol,2011.doi:10.1111/j.1755-3768.2011.02157.x. [Epub ahead of print]
[8]
Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology,2010,117:1792-1799.
[9]
Maruko I, Iida T, Sugano Y, et al. One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy. Retina,2011,31:1921-1927.
[10]
Chan WM, Lai TY, Lai RY, et al. Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. Ophthalmology,2008,115:1756-1765.
Chan WM, Lam DS, Lai TY, et al. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol,2003, 87:1453-1458.
[13]
Schmidt-Erfurth, Michels S, Barbazetto I, et al. Photodynamic effects on choroidal neovascularization and physiological choroid. Invest Ophthalmol Vis Sci,2002,43:830-841.
[14]
Iida T, Kishi S, Hagimura N, et al. Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina,1999,19:508-512.
[15]
Imamura Y, Fujiwara T, Margolis R, et al. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina,2009,29:1469-1473.
[16]
Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy. Retina,2011,31:1603-1608.